Phase II exploratory study of brostallicin PNU-166196A as third/fourth line chemotherapy in adult patients with advanced/metastatic colorectal cancer CRC .
Phase of Trial: Phase II
Latest Information Update: 17 May 2011
At a glance
- Drugs Brostallicin (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 17 May 2011 New trial record